Skip to content
Screener

Lucid Diagnostics LUCD Free cash flow

Free cash flow at other companies

Castle Biosciences logo
Castle BiosciencesCSTL
-$34.58M-221%
Guardant Health logo
Guardant HealthGH
-$71.2M-6.0%
Insight Molecular Diagnostics Inc. logo
Insight Molecular Diagnostics Inc.IMDX
-$10.05M-54.0%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
-$1.76M+73.4%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$1.9M+121%
Personalis, Inc. logo
Personalis, Inc.PSNL
-$25.67M-25.4%

Other financials

Income statement

See full
Revenue$1.5M+26.7%
Gross profit$29.0K+107%
Operating income-$12.8M-12.4%
Net income-$11.7M-163%
EPS (diluted)-$0.10+60.0%

Balance sheet

See full
Cash & equivalents$33.4M+7.4%
Total debt$1.4M-37.5%
Total equity$10.9M+39.0%
Total assets$38.9M+0.7%

Cash flow

See full
Operating cash flow-$11.3M-7.1%
CapEx$21.0K-16.0%

Valuation

See full
Market cap$185.35M+44.4%
Enterprise value$153.36M+54.1%
P/S34×+4.6×

Profitability

See full
Gross margin-57.3%
Operating margin-930.9%-124pp
Net margin-959.8%-187pp
FCF margin-1,040.1%

Returns & leverage

See full
Return on equity-556.3%+139pp
Debt / equity0.1×-0.2×
Current ratio1.3×+0.2×

Where this comes from

Calculated from Lucid Diagnostics’s reported figures.

The source filing: Lucid Diagnostics’s 10-Q, filed August 12, 2026. Open the filing →

Filed
Aug 12, 2026, 4:30 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001437749-26-027335

FAQ

What is Lucid Diagnostics's free cash flow?
Lucid Diagnostics (LUCD) reported free cash flow of -$11.32M in Q2 2026.
How has Lucid Diagnostics's free cash flow changed year-over-year?
Lucid Diagnostics's free cash flow decreased by 7.0% year-over-year, from -$10.57M to -$11.32M.
What is the long-term trend for Lucid Diagnostics's free cash flow?
Over 2 years (2021 to 2024), Lucid Diagnostics's free cash flow has grown at a 54.9% compound annual growth rate (CAGR), from -$18.53M to -$44.44M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.

Ask your AI about Lucid Diagnostics's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude